Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Evaluator-blinded Study to Evaluate Skin Irritation and Sensitization of d-Amphetamine Transdermal System in Healthy Adults

NCT04094025 is registered in ClinicalTrials.gov with Noven Therapeutics as lead sponsor.

NCT NCT04094025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04094025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Evaluator-blinded Study to Evaluate Skin Irritation and Sensitization of d-Amphetamine Transdermal System in Healthy Adults
Lead sponsor
Noven Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
December 2, 2019
Completion date
May 16, 2020
Enrollment
229 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cumulative irritation and sensitization